The Role of Exosomal miRNAs in Promoting Tumor Metastasis: A Molecular Insight
Keywords:
Exosomal miRNAs, Tumor metastasis, miR-21, miR-210, Cross-national analysis, BiomarkersAbstract
Exosomal miRNAs, such as miR-21, miR-10b, and miR-210, play critical roles in tumor progression, particularly in promoting metastasis through tumor microenvironment modulation, immune evasion, and angiogenesis. This study examines the molecular mechanisms and cross-national variability in exosomal miRNA expression linked to metastatic potential across diverse cancer types. We collected exosomal samples from breast, lung, and colorectal cancer patients at various metastatic stages from three countries. Quantitative RT-PCR assessed the expression levels of miR-21, miR-10b, and miR-210. Statistical analyses, including correlation tests and multivariate models, were employed to explore the relationship between miRNA levels and metastatic stages. Elevated levels of miR-21 and miR-210 were positively correlated with increased metastatic potential across all cancer types. Notably, miR-21 showed significant association with advanced stages in breast and colorectal cancers, while miR-210 was predominantly elevated in lung cancer metastases. Cross-national analyses revealed variances in miRNA expression, suggesting potential influences of genetic and environmental factors. Our findings underscore the pivotal role of exosomal miRNAs as both biomarkers and active facilitators of tumor metastasis. The cross-national differences highlight the need for personalized approaches in cancer treatment. Future studies should focus on targeted miRNA inhibition strategies and explore environmental factors affecting miRNA expression.
Downloads
Metrics
References
Chen, G., Huang, A. C., Zhang, W., et al. (2018). Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response. Nature, 560(7718), 382–386.
Hoshino, A., Costa-Silva, B., Shen, T. L., et al. (2015). Tumor exosome integrins determine organotropic metastasis. Nature, 527(7578), 329–335.
Kalluri, R., & LeBleu, V. S. (2020). The biology, function, and biomedical applications of exosomes. Science, 367(6478), eaau6977.
Shao X, Hua S, Feng T, Ocansey DKW, Yin L. Hypoxia-Regulated Tumor-Derived Exosomes, and Tumor Progression: A Focus on Immune Evasion. Int J Mol Sci. 2022 Oct 4;23(19):11789. doi: 10.3390/ijms231911789. PMID: 36233088; PMCID: PMC9570495.
Peinado, H., Lavotshkin, S., & Lyden, D. (2012). Pre-metastatic niches: Organ-specific homes for metastases. Nature Reviews Cancer, 12(1), 39–46.
Svensson, K. J., Kucharzewska, P., Christianson, H. C., et al. (2011). Hypoxia triggers a proangiogenic pathway involving cancer cell microvesicles and PAR-2-mediated VEGF and IL-6 production. PLoS ONE, 6(2), e19773.
Valadi, H., Ekström, K., Bossios, A., et al. (2007). Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nature Cell Biology, 9(6), 654–659.
Wang, M., Yu, F., Ding, H., & Wang, J. (2019). Exosome-based nanotherapeutics: Emerging frontiers in anti-cancer drug delivery. Frontiers in Pharmacology, 10, 713.
Chuang YT, Tang JY, Shiau JP, Yen CY, Chang FR, Yang KH, Hou MF, Farooqi AA, Chang HW. Modulating Effects of Cancer-Derived Exosomal miRNAs and Exosomal Processing by Natural Products. Cancers (Basel). 2023 Jan 3;15(1):318. Doi: 10.3390/cancers15010318. PMID: 36612314; PMCID: PMC9818271.
Duréndez-Sáez E, Torres-Martinez S, Calabuig-Fariñas S, Meri-Abad M, Ferrero-Gimeno M, Camps C. Exosomal microRNAs in non-small cell lung cancer. Transl Cancer Res. 2021 Jun;10(6):3128-3139. doi: 10.21037/tcr-20-2815. PMID: 35116621; PMCID: PMC8798604.
Downloads
Published
How to Cite
Issue
Section
License

This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.